drugset / Trial / NCT04553705

Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)

NCT04553705

RandomizedSequentialDouble-blindTreatment

Summary

The first version of this preprint article is registered on the 4th of May 2020 under the digital object identifier of:10.31219/osf.io/u56fc. COVID-19 infections virus spread worldwide and impact many countries with sever economical sequences. The effective antiviral medication or vaccination for the virus is unavailable until the present date and it takes months or years to discover the effective treatment or test the efficacy of the discovered treatment. Based on these facts, the human immune system against the virus may have an effective role to regulate the infection and reduce the mortality rate among the infected patients. This proposed research article aims to explore the available medication/ natural supplementation to boost the immunity system of the patients against COVID-19 infections and reduce the mortality rate among infected patients. Methods: a proposed clinical trial will be carried out to investigate the effect of the different treatment modalities on the human immune system against COVID-19 infection.

Timeline

Start
2020-09-20
Primary completion
2020-11-04
Completion
2021-12-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Anise seed Unknown 450 mg
Subject Deglycyrrhizinated Licorice Unknown 800 mg
Subject Indian Costus Unknown
Subject Nigella sativa Traditional medicine (herbal / TCM) 1 g
Subject Omega-3 fatty acids Unknown 1000 mg
Subject Quinine Small molecule 1 g